HIV Gene Therapy
CD34+ Cells From HIV Patients Respond To Genetic Manipulation
Published in Gene Therapy Weekly, February 16th, 1998
Recently, U. Junker et al., (Blood 1997;8:4299-4306; and others) demonstrated that granulocyte colony-stimulating factor (G-CSF) could be used to mobilize CD34+ cells in HIV positive individuals without severe side effects or increased viral burden.
Based on this understanding, A. Gervaix and colleagues from the University of California at San Diego, suggested that G-CSF could be used to mobilize sufficient numbers of CD34+ progenitor cells from HIV positive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1998-02-16)
More Articles from Gene Therapy Weekly
- Pathogenesis (Gene Therapy)
Interferons Repress Retrovirus-Mediated Transgene Expression In Vivo - Cancer Gene Therapy
Tetracycline-Responsive Expression System Enhances Suicide Gene Therapy Approach - Combination Therapy
Gene Therapy/Chemotherapy Combination Tested Against Hepatocellular Carcinoma - HIV Gene Therapy
Monkey Study Shows Promise of Gene Therapy Against HIV - Industry News (Joint Venture)
Gene Therapy Delivery Technology Collaboration Announced - Influenza Vaccines
Emergency Human Vaccine Against Hong Kong H5N1 Influenza "Bird Flu" Developed - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
